NSPR InspireMD, Inc. logo

NSPR InspireMD, Inc.

Healthcare
$1.00-2.91%ClosedMarket Cap: $46.8M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

1.68

P/S

4.32

EV/EBITDA

-0.73

DCF Value

$-4.76

FCF Yield

-85.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

28.1%

Operating Margin

-480.6%

Net Margin

-344.1%

ROE

-81.5%

ROA

-66.1%

ROIC

-110.9%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$3.4M$289.0K$
Q4 null$3.1M$-11.8M$
FY null$9.0M$-48.8M$
Q3 null$2.5M$-12.7M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$4.50

Target (Median)

$4.50

Target Range

$3.00 - $6.00

2 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Piper SandlerOverweight
2026-05-05

Trading Activity

Insider Trades

View All
Gleason Shane Thomasofficer: Chief Commercial Officer
SellThu May 21
Gleason Shane Thomasofficer: Chief Commercial Officer
SellThu May 21
Gleason Shane Thomasofficer: Chief Commercial Officer
SellThu May 21
Gleason Shane Thomasofficer: Chief Commercial Officer
SellThu May 21
Gleason Shane Thomasofficer: Chief Commercial Officer
SellThu May 21

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

IL

Exchange

Beta

0.82

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Peers